Stay updated on MGCD516 Study in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MGCD516 Study in Advanced Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record now presents details of the completed Phase 1/1b MGCD516 trial, including its cancer populations, eligibility criteria, study design and outcomes, and participating locations. It also includes study history and related publications.
    Difference
    65%
    Check dated 2026-11-08T01:11:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T19:25:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the changeover.
    Difference
    1%
    Check dated 2026-10-24T22:28:40.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision label in the footer advances from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:28:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 error instead of a study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:20:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with a standard error screen. This change removes the previously visible trial information and keywords, indicating the page is currently inaccessible or access-restricted.
    Difference
    18%
    Check dated 2026-09-19T19:20:58.000Z thumbnail image

Stay in the know with updates to MGCD516 Study in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.